Top Banner
Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen
33

Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Dec 27, 2015

Download

Documents

Randell Elliott
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Chemo-, hormonal-, and targeted therapy

Dr. Judit Toth Department of Oncology

Medical University of Debrecen

Page 2: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Chemotherapy is used for a variety of purposes:

• To cure a specific cancer; • To control tumor growth when cure is not possible; • To relieve symptoms (such as pain) • To shrink tumors before surgery or radiation therapy; • To destroy microscopic cancer cells that may be present

after the known tumor is removed by surgery (called adjuvant therapy). Adjuvant therapy is given to prevent a possible cancer micro-metastases

Page 3: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Chemotherapy Terms

• Adjuvant chemotherapy • Neoadjuvant chemotherapy • Palliative chemotherapy

Page 4: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Neoadjuvant Therapy : Definition

• Neoadjuvant therapy, also named primary therapy or preoperative therapy, is a systemic treatment delivered before the local treatment, such as surgery and/or radiotherapy

Page 5: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Neoadjuvant Therapy

• Rationale– Decrease in the tumor size leading to a more

conservative surgery, and facilitating surgical procedures– To eradicate micrometastases

Page 6: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Neoadjuvant Therapy

• Rationale and Indication– Patients with locally advanced disease– Decrease in the tumor size leading to a more conservative surgery,

and facilitating surgical procedures– To eradicate micrometastases

• Treatment– Chemotherapy– Hormonotherapy– Targeted therapy

Page 7: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.
Page 8: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

8

Cancer and Treatment StrategiesTwo different approachesTwo different approaches

– Local disease Local disease curative treatment• To treat the primary tumor ( local lymph nodes)

• To eradicate micrometastases = adjuvant therapy

– Advanced or metastaticAdvanced or metastatic disease disease• Very occasionally to cure!

Page 9: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

9

Cancer and Treatment Strategies– Local disease Local disease

– Advanced or metastatic disease Advanced or metastatic disease palliative treatment• Advanced disease = unresectable tumor or large regional lymph node involvement

• Metastases

• To controll signs and symptoms of disease• Improve quality of life• Prolong life

• Very occasionally to cure!

Page 10: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

10

ChemotherapyClassification (I)

Family Molecules Targets

Anthracyclines-

Anthracenediones

Doxorubicin

Epirubicin

Idarubicin

Mitoxantrone

Topoisomerase II

DNA

Topo-I Inhibitors Irinotecan

Topotecan

Topoisomerase I

DNA

Antimetabolites Fluorouracil

Methotrexate

Mercaptopurine

Fludarabine

Cytarabine

Gemcitabine

Capecitabine

Puric and pyrimidic bases

Page 11: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

ChemotherapyClassification (II)

Family Molecules Targets

Alkylating agents Cyclophosphamide

Melphalan

Ifosfamide

Busulfan

DNA

Spindle inhibitors Vinorelbine

Vincristine

Vindesine

Vinblastine

Tubuline

Docetaxel

Paclitaxel

Platinum salts Carboplatine

Cisplatine

Oxaliplatine

DNA

Page 12: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.
Page 14: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Side effects of chemotherapy

14

Page 15: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Hair loss: why does it occur?

• Chemotherapy drugs are powerful medications that attack rapidly growing cancer cells.

• Unfortunately, these drugs also attack other rapidly growing cells in body.– including those in hair roots, eyelash, eyebrow,

armpit and other body hair also falls out. Hair usually begins falling out one to three weeks after starting treatment and re-grows three to 10 months after treatment ends.

Page 16: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Side effects of chemotherapy

• Hair loss• Myelo-suppression

Page 17: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Myelosuppression

• Bone marrow suppression is a common side effect of chemotherapy that is characterized by a decrease in blood cell production.

• Myelosuppression can result in the decrease in one, two or all three types of blood cells.– Anemia– Thrombocytopenia– Neutropenia

• Different kinds of growth factors can be used to target the reproduction of red blood cells, white blood cells or platelets.

Page 18: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Side effects of chemotherapy

• Hair loss• Myelo-suppression

• Nausea, Vomiting– Prevention is best defense!

18

Page 19: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

The vomiting centre (VC) in the medulla oblongata, the chemoreceptor trigger zone (CTZ) in the area postrema (AP) on the caudal margin of the IVth ventricle,

aprepitant (Emend®) 

dolasetron (Anzemet®) 

granisetron (Kytril®) 

ondansetron (Zofran®)

palonosetron (Aloxi®) 

proclorperazine (Compazine®) p

romethazine (Anergan®),(Phenergan®)

lorazepam (Ativan®) 

metoclopramide (Reglan®)

dexamethasone (Decadron®) 

famotidine (Pepcid®)

ranitidine (Zantac®) 19

Page 20: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Vomiting and nausea

• Certain chemotherapy drugs are more likely than are others to cause nausea and vomiting:

• Cisplatin• Carboplatin• Oxaliplatin• Cyclophosphamide (Cytoxan)• Doxorubicin or epirubicin• Dacarbazine

• Anti-nausea medications are typically given before treatment !!!

20

Page 21: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Side effects of chemotherapy

• Cardiotoxicity and cardiomyopathy – Fortunately, heart disease associated with

chemotherapy is relatively rare. (Not all chemotherapy drugs carry the potential side effect of heart damage and often temporary :Doxorubicin, 5-FU)

– some newer anti-cancer treatments — such as trastuzumab (Herceptin) for breast cancer — may cause heart damage.

Page 22: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Peripheral neuropathy

• Peripheral neuropathy is caused by damage to nerves, most commonly the sensory nerves (nerves that sense touch, heat or pain).– Pain, burning or tingling in fingers, toes, hands and

feet – Loss of sensation to touch– Muscle weakness and balance problems– Decreased reflexes

22

Page 23: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Skin side effects

• Allergy• Hand foot syndrome (HFS)

23

Page 24: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.
Page 25: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.
Page 26: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.
Page 27: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Nephrotoxicity

• Strong nephrotoxic anticancer agents are: cisplatin and ifosfamide:– cause necrosis of the proximal tubules

• methotrexate:– deposits and blocks the tubule

Sufficient renal function is important before administration of the anticancer drug !

27

Page 28: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Sharp shooter = targeted therapy?

2828

Page 29: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Examples of targets being investigated in cancer treatment

Examples of targeted anticancer therapies approved or in development

General target Specific target Agent or approach

Signal transduction Growth factor receptorsErbB1 (EGFR)ErbB2 (HER2)ErbB1 and ErbB2

Bcr-AblRasRaf

Erlotinib, gefitinibTrastuzumabTyverbImatinibFarnesyl transferase inhibitorsAntisense oligonucleotides

Angiogenesis andmetastasis

VEGFR2VEGF

Matrix metalloproteinasesIntegrins

SunitinibBevacizumabPazopanibAE-941Humanised LM609 mAb

Tumour suppressorgene

p53 p16

Gene therapyGene therapy

Cell-cycle control Cyclin-dependent kinases mTOR

Flavopiridol Temsirolimus (CCI779)Everolimus

2929

Page 30: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Endocrine Therapy

Page 31: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Endocrine Therapy

Less toxic effective method of disease control

Hormone responsive disease: 70% of breast cancer patients (ER/PR+) 90% of prostatic cancer patients Endometrium carcinoma ~1% of other malignancies (Lung, renal cancer)

Page 32: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Hormonal therapy

• The signals from the hormonal receptors "turn on" growth in cells.

• Inhibitors of hormone synthesis:– Analogs of gonadotropin-releasing hormone (GnRH) can

be used to induce a chemical castration– Aromataze inhibitors(letrozol, anastrazol,examestane)

• Hormone receptors antagonists:– Selective Estrogen Receptor Modulators(tamoxifen)– Antiandrogens(nilutamid, flutamide)

Page 33: Chemo-, hormonal-, and targeted therapy Dr. Judit Toth Department of Oncology Medical University of Debrecen.

Thank you if you are still awake